Compare GENB & TALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GENB | TALO |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | N/A | 2017 |
| Metric | GENB | TALO |
|---|---|---|
| Price | $12.25 | $15.62 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $69.50 |
| AVG Volume (30 Days) | 709.7K | ★ 2.3M |
| Earning Date | 05-03-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,780,070,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.00 | $6.23 |
| 52 Week High | $13.95 | $15.70 |
| Indicator | GENB | TALO |
|---|---|---|
| Relative Strength Index (RSI) | 47.80 | 70.62 |
| Support Level | $11.26 | $10.49 |
| Resistance Level | $13.70 | N/A |
| Average True Range (ATR) | 0.96 | 0.55 |
| MACD | -0.00 | 0.21 |
| Stochastic Oscillator | 39.81 | 92.28 |
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. The revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.